DossierENTITY

infectious disease research and development

Coverage of infectious disease research and development in the Nexus archive.

Earliest in view: May 26 · 11:50 UTCMost recent: May 26 · 11:50 UTC

Co-mentioned in this coverage

Recent coverage

BUSINESSMay 26 · 11:50 UTCCNBC TOP
Eli Lilly stock edges higher as company plans nearly $4 billion in vaccine deals
Eli Lilly's stock increased as the company plans nearly $4 billion in vaccine deals to expand into infectious disease research and development.